Bridgeway Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Bridgeway Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,992	Closed	-$382K	–	1249
2026 Q1	$382K	Sell	41,992 -10,000	-19%	-$126K	0.01%	877
2025 Q4	$711K	Sell	51,992 -15,000	-22%	-$278K	0.01%	759
2025 Q3	$1.46M	Hold	66,992	–	–	0.03%	633
2025 Q2	$800K	Hold	66,992	–	–	0.02%	691
2025 Q1	$797K	Hold	66,992	–	–	0.02%	676
2024 Q4	$1.03M	Hold	66,992	–	–	0.02%	664
2024 Q3	$751K	Hold	66,992	–	–	0.02%	751
2024 Q2	$361K	Hold	66,992	–	–	0.01%	928
2024 Q1	$456K	Hold	66,992	–	–	0.01%	950
2023 Q4	$455K	Hold	66,992	–	–	0.01%	962
2023 Q3	$336K	Buy	+66,992	New	+$399K	0.01%	989
2020 Q1	–	Sell	-10,500	Closed	-$50K	–	1292
2019 Q4	$50K	Buy	+10,500	New	+$43.4K	﹤0.01%	1277

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Bridgeway Capital Management's CLPT Position: Q2 2026 in Review

Bridgeway Capital Management sold out of ClearPoint Neuro (CLPT) in Q2 2026, closing a stake of 41,992 shares — an estimated $382K sold.

Bridgeway Capital Management first reported a position in CLPT in Q4 2019 and held it in 12 quarters. The position peaked at $1.46M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Bridgeway Capital Management reported no remaining ClearPoint Neuro position as of Q2 2026 after selling out during the quarter.
Bridgeway Capital Management sold 41,992 ClearPoint Neuro shares in Q2 2026, an estimated $382K.
Bridgeway Capital Management first reported a position in ClearPoint Neuro in Q4 2019 and held it in 12 quarters.
Bridgeway Capital Management's ClearPoint Neuro position peaked at $1.46M in Q3 2025.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.